Current Guidance
Pediatric MMR (Measles, Mumps, Rubella) Guidance
- Age 0 to 6 months: Children are not eligible for the vaccine.
- Age 6 to 12 months: The vaccine should be administered if the child is traveling to endemic countries in Africa and Asia (including India)
- 12 months: Recommended age for first dose of MMR
- 4 years: Recommended age for the second dose of MMR
- Post-exposure dosing: If a child between 6 months and 4 years is exposed to measles; a dose can be administered before the usual schedule listed above. Early dosing is not otherwise recommended.
Adult MMR (Measles, Mumps, Rubella) Guidance
- Born before 1957: Considered immune due to widespread circulating measles
- Born after 1967: Considered immune if there is documentation of receiving 2 measles vaccines
- Born between 1957-1967: Due to the likelihood of a less effective vaccine given during this timeframe, it is reasonable to receive a booster dose of MMR
- If you were born after 1967 and there is no written documentation of measles vaccination, but you are confident that you received the standard childhood vaccines, we would not recommend re-immunization.
Weight Loss Drugs
GLP-1 medications like Ozempic have been in use since 2005. GLP-1 therapy was only used for diabetes until 2021, when approval for weight loss was granted. These injectable medications have proven to be a safe and effective way to lose 10-20% of body weight for those who are overweight.
Insurance coverage for these medications varies widely. If you would like to consider treatment with one of these medications, please investigate your insurance coverage using the links below before scheduling a visit to discuss with your provider.
If your insurer grants initial approval for treatment, we will likely need to see you for follow-up visits to verify the medication's efficacy, which is essential for continued approval by your insurer.
